News | October 07, 2013

Switzerland's Hôpital Riviera Improves Confidence in Patient Treatment with Elekta's Identify Solution

Radiotherapy clinic uses RFID to track patients and equipment

radiation therapy elekta vmat mosaiq hopital riviera

October 7, 2013 — As a new medical center, Hôpital Riviera's daily radiotherapy patient volume started out small, but now the hospital averages 40 patients per day. The introduction of Volumetric Modulated Arc Therapy (VMAT) in many more cases has resulted in a substantial reduction in the time slot — from 15-20 minutes down to 10-15 minutes — which has enabled a 50 percent increase in patients treated per day.

To ensure optimal patient and accessory identification in its busy radiation oncology department, Hôpital Riviera has begun using Elekta's Identify system.

Identify verifies the right patient once the patient enters the treatment room, and its integration with Elekta's Mosaiq Oncology Information System ensures the right accessories are present for each patient's treatment session. Identify is based on advanced radiofrequency identification (RFID) technology, which automates the identification of the patient and accessories and provides independent verification.

"Our main reason for purchasing Identify was enhancing patient security as an error-prevention measure as our volume increased," says Dr. Marc Pachoud, Ph.D., medical physicist, Hopital Riviera. "We had been using a manual checklist system. A bar code system was an option, but that would be too time-consuming for the technicians to do manual scanning. With Identify, patient identification is completely automated — there's nothing required of the technicians. The system checks the patient's identity from an RFID (radio-frequency identification) card and everything that is on the couchtop for the patient's treatment."

Pachoud observed that a key advantage of Identify at Hôpital Riviera is removing a burden from technicians, so they can concentrate on the patient's treatment.

"The technicians are definitely less stressed now," he said. "If you decrease technician stress, I think that improves patient safety…. (Technicians) are much more confident in their patient care responsibilities."

For more information: www.elekta.com

Related Content

Varian to Showcase Latest Radiation Therapy Technologies and Software at ASTRO 2017
News | Radiation Therapy | September 19, 2017
Varian Medical Systems announced it will be demonstrating its new Halcyon platform and HyperArc high-definition...
Elekta to Highlight MOSAIQ Oncology Analytics at ASTRO Annual Meeting
News | Radiation Therapy | September 19, 2017
September 19, 2017 — Elekta will highlight its Mosaiq Oncology...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Clinical Trials and Cutting-Edge Radiation Oncology Research to Be Featured at ASTRO 2017
News | Radiation Therapy | September 14, 2017
The program for the 2017 Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 24-27 in San...
Provision Healthcare Joins RayCare Clinical Partners
News | Oncology Information Management Systems (OIMS) | September 11, 2017
Provision, located in Knoxville, Tenn., is the latest to partner with RaySearch Laboratories on the development of its...
U.K.'s NICE Supports Use of Hydrogel Spacer in Prostate Cancer Treatement
News | Patient Positioning Radiation Therapy | September 08, 2017
Augmenix Inc. announced that the National Institute for Health and Care Excellence (NICE) in the U.K. has issued...
Sponsored Content | Videos | Radiation Therapy | September 08, 2017
The new Visicoil MR is a helically-wound, flexible linear fiducial marker.
FDG-PET/CT Predicts Melanoma Patients' Response to Immune Checkpoint Inhibitor Therapy
News | PET-CT | September 07, 2017
September 7, 2017 — Advanced melanoma has a poor prognosis, but immune checkpoint inhibitor therapy can be effective
Augmenix Announces Medicare Administrative Contractor Palmetto Coverage for SpaceOAR Hydrogel
News | Patient Positioning Radiation Therapy | September 05, 2017
Augmenix Inc. announced that Palmetto GBA LLC — the Medicare Administrative Contractor (MAC) covering North Carolina,...
Penn Medicine to Host Fourth Annual Proton Therapy Training Course
News | Proton Therapy | August 30, 2017
August 30, 2017 — IBA (Ion Beam Applications S.A.) and the Department of Radiation Oncology at Penn Medicine, in part
Overlay Init